U.S. market Closed. Opens in 17 hours 15 minutes

RMD | ResMed Inc. Stock Fundamentals

(Stock Exchange: NYSE)
Analyzing fundamentals for RMD we got that it has strong fundamentals where Valuation is considered to be fairly valued, Profitability is stunning wealthy, Growth is exceptionally good and Health is very strong.

Valuation (57%)

Company Industry
P/E Ratio (TTM) 36.08 52.02
PEG Ratio (TTM) 2.94 3.81
P/S Ratio (TTM) 8.10 12.48
P/B Ratio (TTM) 7.57 6.63
P/FCF Ratio (TTM) 28.64 331.58
Price to 5YR AVG Earnings Ratio 57.37 115.37
Price to 5YR AVG FCF Ratio 54.87 87.71

Profitability (85%)

Company Industry
ROA (TTM) 14.86% 6.95%
ROE (TTM) 22.41% 12.91%
Net Profit Margin (TTM) 22.46% 2.69%
ROIC 5YR AVG 24.10% 11.07%

Growth (83%)

4QTR AVG 3YR AVG 5YR AVG
EPS 8.01% 30.49% 23.90%
Revenue 2.93% 11.16% 12.49%
Net Income 7.97% 31.42% 24.63%
Cash Flow 18.18% 4.75% 42.76%

Health (74%)

Company Industry
Current Ratio (TTM) 2.59 3.38
Quick Ratio (TTM) 1.69 2.56
D/E Ratio (TTM) 0.15 0.39
Interest Coverage (TTM) -28.88 27.94
Piotroski F-Score 6 6
Altman Z-Score 13.52 23.15
LTL to 5YR AVG FCF 1.04 4.39
Shares Outstanding Growth 5YR AVG 0.54% 2.69%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙